Novel Hybrid Conjugates with Dual Estrogen Receptor α Degradation and Histone Deacetylase Inhibitory Activities for Breast Cancer Therapy

2021 ◽  
pp. 116185
Author(s):  
Chenxi Zhao ◽  
Chu Tang ◽  
Changhao Li ◽  
Wentao Ning ◽  
Zhiye Hu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Cancer Therapy ◽  
Histone Deacetylase ◽  
Estrogen Receptor Α ◽  
Breast Cancer Therapy ◽  
Inhibitory Activities

Enhanced noscapine delivery using estrogen-receptor-targeted nanoparticles for breast cancer therapy

2014 ◽  
pp. 1
Author(s):  
Jitender Madan ◽  
Sushma R. Gundala ◽  
Yoganjaneyulu Kasetti ◽  
Prasad V. Bharatam ◽  
Ritu Aneja ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Cancer Therapy ◽  
Breast Cancer Therapy ◽  
Targeted Nanoparticles

Cover Picture: A Chimeric SERM-Histone Deacetylase Inhibitor Approach to Breast Cancer Therapy (ChemMedChem 3/2014)

ChemMedChem ◽  
2014 ◽  
Vol 9 (3) ◽  
pp. 413-413
Author(s):  
Hitisha K. Patel ◽  
Marton I. Siklos ◽  
Hazem Abdelkarim ◽  
Emma L. Mendonca ◽  
Aditya Vaidya ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Therapy ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Breast Cancer Therapy ◽  
Deacetylase Inhibitor

scholarly journals A Novel Strategy to Co-target Estrogen Receptor and Nuclear Factor κB Pathways with Hybrid Drugs for Breast Cancer Therapy

2017 ◽  
Vol 8 (3) ◽  
pp. 135-142 ◽  
Author(s):  
Irida Kastrati ◽  
Marton I. Siklos ◽  
Svitlana D. Brovkovych ◽  
Gregory R. J. Thatcher ◽  
Jonna Frasor
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Cancer Therapy ◽  
Nuclear Factor Κb ◽  
Nuclear Factor ◽  
Breast Cancer Therapy ◽  
Hybrid Drugs ◽  
Novel Strategy
Sign in / Sign up

Export Citation Format

Share Document